Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHKW6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,396
Award facts
- Contract value 100% obligated
- $14,396.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $14,396.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 100 unit vials. The contract, awarded on January 22, 2026, represents a firm fixed-price delivery order with an ultimate completion date of February 12, 2026. No set-aside designation was utilized for this procurement, indicating the award was made through unrestricted competition. DMS Pharmaceutical Group will fulfill this requirement from its Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to provide comprehensive pharmaceutical support to military healthcare facilities. The parent contract, valued at $499,999,999 with a completion date of December 31, 2036, was awarded on November 13, 2025, and authorizes DLA to issue delivery orders for branded and generic pharmaceuticals, biologics, and medical consumables. DMS Pharmaceutical Group's established performance across numerous prior delivery orders demonstrates its capability to meet the specialized pharmaceutical requirements of Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FHKW6?
SPE2DR26FHKW6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FHKW6 worth?
The government has obligated $14,396 on SPE2DR26FHKW6.
Is contract SPE2DR26FHKW6 an order under another contract?
Yes. SPE2DR26FHKW6 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKW6 competed?
The extent of competition for SPE2DR26FHKW6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award